Insider Trading - Day One Biopharmaceuticals Inc. (DAWN)

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Day One Biopharmaceuticals Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-06-01
Purchase
2021-06-01
9:50 pm
Day One Biopharmaceuticals Inc. DAWN Becker Daniel J.
Director
5,000 $16 $80,000 68,000
(Direct)
View
2021-06-01
Purchase
2021-06-01
9:51 pm
Day One Biopharmaceuticals Inc. DAWN Josey John A.
Director
7,000 $16 $112,000 136,473
(Direct)
View
2021-06-01
Purchase
2021-06-02
5:12 pm
Day One Biopharmaceuticals Inc. DAWN Canaan XI L.P.
Canaan Partners XI LLC
10% Owner
13,000 $16 $208,000 10,735,645
(Direct)
View
2021-02-01
Purchase
2021-06-02
6:40 pm
Day One Biopharmaceuticals Inc. DAWN Atlas Venture Fund XI L.P.
Atlas Venture Associates Opportunity I LLC
Atlas Venture Opportunity Fund I L.P.
Atlas Venture Associates Opportunity I L.P.
Atlas Venture Associates XI L.P.
Atlas Venture Associates XI LLC
10% Owner
500,000 $16 $8,000,000 991,396
(Indirect)
View
2021-02-01
Purchase
2021-06-02
8:52 pm
Day One Biopharmaceuticals Inc. DAWN Grant Papanek Julie
Director
13,000 $16 $208,000 11,411,924
(Indirect
Direct)
View
2021-06-01
Purchase
2021-06-03
4:42 pm
Day One Biopharmaceuticals Inc. DAWN AI Day 1 LLC
Access Industries Holdings LLC
ACCESS INDUSTRIES MANAGEMENT LLC
Blavatnik Len
10% Owner
875,000 $16 $14,000,000 9,377,776
(Direct)
View
2021-12-01
Sale
2021-12-03
7:19 pm
Day One Biopharmaceuticals Inc. DAWN Blackman Samuel C.
Chief Medical Officer
10,000 $17.22 $172,242 2,376,718
(Indirect
Direct)
View
2021-12-03
Sale
2021-12-07
06:01 am
Day One Biopharmaceuticals Inc. DAWN TAKEDA PHARMACEUTICAL CO LTD
Takeda Pharmaceuticals U.S.A. Inc.
MILLENNIUM PHARMACEUTICALS INC
Takeda Ventures Inc.
10% Owner
110,209 $18.1 $1,994,530 6,417,397
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-06-01
Option Award
2021-06-01
9:50 pm
N/A
2031-05-25
Day One Biopharmaceuticals Inc. DAWN Becker Daniel J.
Director
63,000 $0 68,000
(Direct)
View
2021-06-01
Option Award
2021-06-01
9:51 pm
N/A
2031-05-25
Day One Biopharmaceuticals Inc. DAWN Josey John A.
Director
64,181 $0 136,473
(Direct)
View
2021-06-01
Conversion
2021-06-02
5:12 pm
N/A
N/A
Day One Biopharmaceuticals Inc. DAWN Canaan XI L.P.
Canaan Partners XI LLC
10% Owner
7,476,776 $0 10,735,645
(Direct)
View
2021-02-01
Conversion
2021-06-02
6:40 pm
N/A
N/A
Day One Biopharmaceuticals Inc. DAWN Atlas Venture Fund XI L.P.
Atlas Venture Associates Opportunity I LLC
Atlas Venture Opportunity Fund I L.P.
Atlas Venture Associates Opportunity I L.P.
Atlas Venture Associates XI L.P.
Atlas Venture Associates XI LLC
10% Owner
8,502,776 $0 991,396
(Indirect)
View
2021-02-01
Option Award
2021-06-02
8:52 pm
N/A
N/A
Day One Biopharmaceuticals Inc. DAWN Grant Papanek Julie
Director
211,279 $0 11,411,924
(Indirect)
View
2021-02-01
Conversion
2021-06-02
8:52 pm
N/A
N/A
Day One Biopharmaceuticals Inc. DAWN Grant Papanek Julie
Director
7,476,776 $0 11,411,924
(Indirect)
View
2021-06-01
Conversion
2021-06-03
4:42 pm
N/A
N/A
Day One Biopharmaceuticals Inc. DAWN AI Day 1 LLC
Access Industries Holdings LLC
ACCESS INDUSTRIES MANAGEMENT LLC
Blavatnik Len
10% Owner
17,005,552 $0 9,377,776
(Direct)
View
2021-08-16
Option Award
2021-08-18
7:03 pm
N/A
2031-08-15
Day One Biopharmaceuticals Inc. DAWN Garland J. Scott
Director
48,072 $0 48,072
(Direct)
View
2021-11-24
Other
2021-11-29
5:16 pm
N/A
N/A
Day One Biopharmaceuticals Inc. DAWN TAKEDA PHARMACEUTICAL CO LTD
Takeda Pharmaceuticals U.S.A. Inc.
MILLENNIUM PHARMACEUTICALS INC
Takeda Ventures Inc.
10% Owner
57,224 $0 6,584,830
(Indirect)
View
2021-11-24
Other
2021-11-29
5:30 pm
N/A
N/A
Day One Biopharmaceuticals Inc. DAWN Atlas Venture Fund XI L.P.
10% Owner
801,138 $0 8,011,380
(Direct)
View
2021-12-01
Gift
2021-12-03
7:19 pm
N/A
N/A
Day One Biopharmaceuticals Inc. DAWN Blackman Samuel C.
Chief Medical Officer
1,000,000 $0 2,376,718
(Direct)
View